At BIO International Convention 2026, Sarah-Jane Demy discusses improving biotech investment, renewed NIH support for emerging companies, and why capital access remains one of the industry's biggest priorities.
Sara Jane Demy
Advertisement
Sara Jane Demy is the CEO & Founder of Demy-Colton, a leading biotech and life sciences events organization.
Articles by Sara Jane Demy
Advertisement
Latest Updated Articles
Advertisement
Advertisement